MacRae Holden, Mefford Karl, Pepperdine University
International Journal of Sport Nutrition and Exercise Metabolism, 2006, 16, 405-419
We investigated whether 6 wk of antioxidant supplementation (AS) would enhance 30 km time
trial (TT) cycling performance. Eleven elite male cyclists completed a randomized, double-blind,
cross-over study to test the effects of twice daily AS containing essential vitamins plus
quercetin (FRS), and AS minus quercetin (FRS-Q) versus a baseline TT (B). MANOVA analysis
showed that time to complete the 30 km TT was improved by 3.1% on FRS compared to B (P
< 0.01), and by 2% over the last 5 km (P < 0.05). Absolute and relative (%HRmax) heart rates
and percent VO2max were not different between trials, but average and relative power (% peak
power) was higher on FRS (P < or = 0.01). Rates of carbohydrate and fat oxidation were not
different between trials. Thus, FRS supplementation significantly improved high-intensity
cycling TT performance through enhancement of power output. Further study is needed to
determine the potential mechanism(s) of the antioxidant efficacy.
Commentary on the study:
Lead Researcher Dr. Holden MacRae says of the results:
“Exercise performance changes of 1-4% are significant and usually mean the difference
between winning and losing. Changes of this magnitude are typically achieved in athletes only
by blood doping or living at high altitude. Daily use of FRS improved high intensity cycling
time-trial performance by 3.1%, a very significant effect purely through consumption of a liquid
dietary supplement.”
Dr. Marcus C.C.W. Elliott, MD, a Harvard-trained physician specializing in exercise physiology
and a FRS Company advisor, believes that FRS also has powerful cross-over applications for
casual athletes as well as the non-athletic by preventing oxidative cell damage and increasing
energy for daily activity. According to Dr. Elliott:
“For over a decade I’ve believed that our next breakthrough in athletic performance would
involve a powerful antioxidant cocktail. From these impressive study results, I now think FRS
may be that breakthrough.”